Spores of Bacillus coagulans GBI-30, 6086 show high germination, survival and enzyme activity in a dynamic, computer-controlled in vitro model of the gastrointestinal tract
In: Beneficial MicrobesSearch for other papers by D. Keller in
Current site
Google Scholar
Search for other papers by S. Verbruggen in
Current site
Google Scholar
Search for other papers by H. Cash in
Current site
Google Scholar
Search for other papers by S. Farmer in
Current site
Google Scholar
Beneficial Microbes Consultancy, Johan Karschstraat 3, 6709 TN Wageningen, the Netherlands.
Search for other papers by K. Venema in
Current site
Google Scholar
The aim of this study was to assess the germination, survival and metabolic activity of the probiotic Bacillus coagulans GBI-30, 6086 [GanedenBC30] (BC30) in a dynamic, computer controlled in vitro model of the gastrointestinal (GI) tract, simulating human adults. Experiments were performed in the presence of a meal to maximise germination, due to the presence of germination-triggers. Both an upper GI tract (stomach and small intestine; TIM-1) and a colon model (TIM-2) were used, where material exiting TIM-1 was added to TIM-2. Spores of BC30 were introduced in the gastric compartment of TIM-1 and samples were taken immediately after the pylorus. Moreover, for 6 h, every hour the ileal efflux was collected and a subsample was plated for viable counts (spores and germinated cells). The remainder of the sample was fed to TIM-2, and after 24 h another sample was taken and tested for viable counts. In addition, samples were taken from the dialysates of the model and analysed using LC-MS/MS to determine bacterial metabolites and digestion products. Survival after transit through the gastric compartment was high (97%) and most cells were still in the spore form (76%). Survival after transit through TIM-1 was on average 51%, meaning that on average half of the orally provided spores was found back as cfu on the agar plates. Of these on average 93% were germinated cells and only 7% were spores. 24 h after the start of the experiments germination had increased in TIM-2 to 97% vegetative cells, and only 3% spores. No further loss of viability was observed in TIM-2. In terms of metabolic activity, increased levels of amino acids, dipeptides and citric acid cycle metabolites were found compared to experiments in the absence of BC30. In conclusion, BC30 spores germinate to a large extent (>90%) in the presence of germination triggers in the small intestine in a model that closely mimics the physiological conditions of human adults. Of the oral dose, as much as half of the cells survived transit through the upper GI tract, and based on the metabolite profile, these cells were metabolically active. Either these cells or the enzymes released from the dead cells aided in digestion of the meal. These insights help explain some of the observations in previous experiments, and support the understanding of the mechanism of action of the probiotic BC30.
-
Adams, C.A., 2010. The probiotic paradox: live and dead cells are biological response modifiers. Nutrition Research Reviews 23: 37-46.
'The probiotic paradox: live and dead cells are biological response modifiers ' () 23 Nutrition Research Reviews : 37 -46.
-
Aguirre, M., Ramiro-Garcia, J., Koenen, M.E. and Venema, K., 2014. To pool or not to pool? Impact of the use of individual and pooled fecal samples for in vitro fermentation studies. Journal of Microbiological Methods 107: 1-7.
'To pool or not to pool? ' () 107 Journal of Microbiological Methods : 1 -7.
-
Andersson, A., Granum, P.E. and Ronner, U., 1998. The adhesion of Bacillus cereus spores to epithelial cells might be an additional virulence mechanism. International Journal of Food Microbiology 39: 93-99.
'The adhesion of Bacillus cereus spores to epithelial cells might be an additional virulence mechanism ' () 39 International Journal of Food Microbiology : 93 -99.
-
Baccigalupi, L., Ricca, E. and Ghelardi, E., 2015. Non-LAB probiotics: spore formers. In: Venema, K. and Do Carmo, A.P. (eds.) Probiotics and prebiotics: current research and future trends. Caister Academic Press, Poole, UK, pp. 93-104.
'Non-LAB probiotics: spore formers ', in Probiotics and prebiotics: current research and future trends , () 93 -104.
-
Bader, J., Albin, A. and Stahl, U., 2012. Spore-forming bacteria and their utilisation as probiotics. Beneficial Microbes 3: 67-75.
'Spore-forming bacteria and their utilisation as probiotics ' () 3 Beneficial Microbes : 67 -75.
-
Baron, M., 2009. A patented strain of Bacillus coagulans increased immune response to viral challenge. Postgraduate Medicine 121: 114-118.
'A patented strain of Bacillus coagulans increased immune response to viral challenge ' () 121 Postgraduate Medicine : 114 -118.
-
Bernardeau, M., Lehtinen, M.J., Forssten, S.D. and Nurminen, P., 2017. Importance of the gastrointestinal life cycle of Bacillus for probiotic functionality. Journal of Food Science and Technology 54: 2570-2584.
'Importance of the gastrointestinal life cycle of Bacillus for probiotic functionality ' () 54 Journal of Food Science and Technology : 2570 -2584.
-
Casula, G. and Cutting, S.M., 2002. Bacillus probiotics: spore germination in the gastrointestinal tract. Applied and Environmental Microbiology 68: 2344-2352.
'Bacillus probiotics: spore germination in the gastrointestinal tract ' () 68 Applied and Environmental Microbiology : 2344 -2352.
-
Ceragioli, M., Cangiano, G., Esin, S., Ghelardi, E., Ricca, E. and Senesi, S., 2009. Phagocytosis, germination and killing of Bacillus subtilis spores presenting heterologous antigens in human macrophages. Microbiology 155: 338-346.
'Phagocytosis, germination and killing of Bacillus subtilis spores presenting heterologous antigens in human macrophages ' () 155 Microbiology : 338 -346.
-
Cutting, S.M., 2011. Bacillus probiotics. Food Microbiology 28: 214-220.
'Bacillus probiotics ' () 28 Food Microbiology : 214 -220.
-
Dolin, B.J., 2009. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. Methods and Findings in Experimental and Clinical Pharmacology 31: 655-659.
'Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome ' () 31 Methods and Findings in Experimental and Clinical Pharmacology : 655 -659.
-
Duc le, H., Hong, H.A., Uyen, N.Q. and Cutting, S.M., 2004. Intracellular fate and immunogenicity of B. subtilis spores. Vaccine 22: 1873-1885.
'Intracellular fate and immunogenicity of B. subtilis spores ' () 22 Vaccine : 1873 -1885.
-
Fakhry, S., Sorrentini, I., Ricca, E., De Felice, M. and Baccigalupi, L., 2008. Characterization of spore forming Bacilli isolated from the human gastrointestinal tract. Journal of Applied Microbiology 105: 2178-2186.
'Characterization of spore forming Bacilli isolated from the human gastrointestinal tract ' () 105 Journal of Applied Microbiology : 2178 -2186.
-
Food and Agriculture Organisation (FAO), 2001. Joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food: health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO, Rome, Italy.
-
Hatanaka, M., Nakamura, Y., Maathuis, A.J., Venema, K., Murota, I. and Yamamoto, N., 2012. Influence of Bacillus subtilis C-3102 on microbiota in a dynamic in vitro model of the gastrointestinal tract simulating human conditions. Beneficial Microbes 3: 229-236.
'Influence of Bacillus subtilis C-3102 on microbiota in a dynamic in vitro model of the gastrointestinal tract simulating human conditions ' () 3 Beneficial Microbes : 229 -236.
-
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology 11: 506-514.
'Expert consensus document ' () 11 Nature Reviews Gastroenterology & Hepatology : 506 -514.
-
Hoa, T.T., Duc, L.H., Isticato, R., Baccigalupi, L., Ricca, E., Van, P.H. and Cutting, S.M., 2001. Fate and dissemination of Bacillus subtilis spores in a murine model. Applied and Environmental Microbiology 67: 3819-3823.
'Fate and dissemination of Bacillus subtilis spores in a murine model ' () 67 Applied and Environmental Microbiology : 3819 -3823.
-
Hong, H.A., Le, H.D. and Cutting, S.M., 2005. The use of bacterial spore formers as probiotics. FEMS Microbiology Reviews 29: 813-835.
'The use of bacterial spore formers as probiotics ' () 29 FEMS Microbiology Reviews : 813 -835.
-
Hun, L., 2009. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS. Postgraduate Medicine 121: 119-124.
'Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS ' () 121 Postgraduate Medicine : 119 -124.
-
Jager, R., Shields, K.A., Lowery, R.P., De Souza, E.O., Partl, J.M., Hollmer, C., Purpura, M. and Wilson, J.M., 2016. Probiotic Bacillus coagulans GBI-30, 6086 reduces exercise-induced muscle damage and increases recovery. PeerJ 4: e2276.
'Probiotic Bacillus coagulans GBI-30, 6086 reduces exercise-induced muscle damage and increases recovery ' () 4 PeerJ : e2276.
-
Kalman, D.S., Schwartz, H.I., Alvarez, P., Feldman, S., Pezzullo, J.C. and Krieger, D.R., 2009. A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms. BMC Gastroenterology 9: 85.
'A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms ' () 9 BMC Gastroenterology : 85.
-
Keller, D., Van Dinter, R., Cash, H., Farmer, S. and Venema, K., 2017. Bacillus coagulans GBI-30, 6086 increases plant protein digestion in a dynamic, computer-controlled in vitro model of the small intestine (TIM-1). Beneficial Microbes 8: 491-496.
'Bacillus coagulans GBI-30, 6086 increases plant protein digestion in a dynamic, computer-controlled in vitro model of the small intestine (TIM-1) ' () 8 Beneficial Microbes : 491 -496.
-
Kimmel, M., Keller, D., Farmer, S. and Warrino, D.E., 2010. A controlled clinical trial to evaluate the effect of GanedenBC(30) on immunological markers. Methods and Findings in Experimental and Clinical Pharmacology 32: 129-132.
'A controlled clinical trial to evaluate the effect of GanedenBC(30) on immunological markers ' () 32 Methods and Findings in Experimental and Clinical Pharmacology : 129 -132.
-
Lau, S., 2014. Oral application of bacterial lysate in infancy diminishes the prevalence of atopic dermatitis in children at risk for atopy. Beneficial Microbes 5: 147-149.
'Oral application of bacterial lysate in infancy diminishes the prevalence of atopic dermatitis in children at risk for atopy ' () 5 Beneficial Microbes : 147 -149.
-
Maathuis, A., Hoffman, A., Evans, A., Sanders, L. and Venema, K., 2009. The effect of the undigested fraction of maize products on the activity and composition of the microbiota determined in a dynamic in vitro model of the human proximal large intestine. Journal of the American College of Nutrition 28: 657-666.
'The effect of the undigested fraction of maize products on the activity and composition of the microbiota determined in a dynamic in vitro model of the human proximal large intestine ' () 28 Journal of the American College of Nutrition : 657 -666.
-
Maathuis, A.J., Keller, D. and Farmer, S., 2010. Survival and metabolic activity of the GanedenBC30 strain of Bacillus coagulans in a dynamic in vitro model of the stomach and small intestine. Beneficial Microbes 1: 31-36.
'Survival and metabolic activity of the GanedenBC30 strain of Bacillus coagulans in a dynamic in vitro model of the stomach and small intestine ' () 1 Beneficial Microbes : 31 -36.
-
Maathuis, A.J., Van den Heuvel, E.G. Schoterman, M.H. and Venema, K., 2012. Galacto-oligosaccharides have prebiotic activity in a dynamic in vitro colon model using a (13)C-labeling technique. Journal of Nutrition 142: 1205-1212.
'Galacto-oligosaccharides have prebiotic activity in a dynamic in vitro colon model using a (13)C-labeling technique ' () 142 Journal of Nutrition : 1205 -1212.
-
Mandel, D.R., Eichas, K. and Holmes, J., 2010. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complementary and Alternative Medicine 10: 1.
'Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial ' () 10 BMC Complementary and Alternative Medicine : 1.
-
Marteau, P., Minekus, M., Havenaar, R. and Huis in’t Veld, J.H., 1997. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. Journal of Dairy Science 80: 1031-1037.
'Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile ' () 80 Journal of Dairy Science : 1031 -1037.
-
Minekus, M., 1998. Development and validation of a dynamic model of the gastrointestinal tract. PhD-thesis, Utrecht University, Utrecht, the Netherlands, 174 pp.
'Development and validation of a dynamic model of the gastrointestinal tract ', () 174.
-
Minekus, M., Marteau, P., Havenaar, R. and Huis in’t Veld, J.H.J., 1995. A multicompartmental dynamic computer-controlled model simulating the stomach and small intestine. Alternatives to Laboratory Animals 23: 197-209.
'A multicompartmental dynamic computer-controlled model simulating the stomach and small intestine ' () 23 Alternatives to Laboratory Animals : 197 -209.
-
Sanchez, B., Arias, S., Chaignepain, S., Denayrolles, M., Schmitter, J.M., Bressollier, P. and Urdaci, M.C., 2009. Identification of surface proteins involved in the adhesion of a probiotic Bacillus cereus strain to mucin and fibronectin. Microbiology 155: 1708-1716.
'Identification of surface proteins involved in the adhesion of a probiotic Bacillus cereus strain to mucin and fibronectin ' () 155 Microbiology : 1708 -1716.
-
Setlow, P., 2014. Germination of spores of Bacillus species: what we know and do not know. Journal of Bacteriology 196: 1297-1305.
'Germination of spores of Bacillus species: what we know and do not know ' () 196 Journal of Bacteriology : 1297 -1305.
-
Spinosa, M.R., Braccini, T., Ricca, E., De Felice, M., Morelli, L., Pozzi, G. and Oggioni, M.R., 2000. On the fate of ingested Bacillus spores. Research in Microbiology 151: 361-368.
'On the fate of ingested Bacillus spores ' () 151 Research in Microbiology : 361 -368.
-
Tam, N.K., Uyen, N.Q., Hong, H.A., Duc le, H., Hoa, T.T., Serra, C.R., Henriques, A.O. and Cutting, S.M., 2006. The intestinal life cycle of Bacillus subtilis and close relatives. Journal of Bacteriology 188: 2692-2700.
'The intestinal life cycle of Bacillus subtilis and close relatives ' () 188 Journal of Bacteriology : 2692 -2700.
-
Thwaite, J.E., Laws, T.R., Atkins, T.P. and Atkins, H.S., 2009. Differential cell surface properties of vegetative Bacillus. Letters in Applied Microbiology 48: 373-378.
'Differential cell surface properties of vegetative Bacillus ' () 48 Letters in Applied Microbiology : 373 -378.
Supplementary Materials
Spores of Bacillus coagulans GBI-30, 6086 show high germination, survival and enzyme activity in a dynamic, computer-controlled in vitro model of the gastrointestinal tract
In: Beneficial MicrobesSearch for other papers by D. Keller in
Current site
Google Scholar
PubMed
Search for other papers by S. Verbruggen in
Current site
Google Scholar
PubMed
Search for other papers by H. Cash in
Current site
Google Scholar
PubMed
Search for other papers by S. Farmer in
Current site
Google Scholar
PubMed
Beneficial Microbes Consultancy, Johan Karschstraat 3, 6709 TN Wageningen, the Netherlands.
Search for other papers by K. Venema in
Current site
Google Scholar
PubMed
The aim of this study was to assess the germination, survival and metabolic activity of the probiotic Bacillus coagulans GBI-30, 6086 [GanedenBC30] (BC30) in a dynamic, computer controlled in vitro model of the gastrointestinal (GI) tract, simulating human adults. Experiments were performed in the presence of a meal to maximise germination, due to the presence of germination-triggers. Both an upper GI tract (stomach and small intestine; TIM-1) and a colon model (TIM-2) were used, where material exiting TIM-1 was added to TIM-2. Spores of BC30 were introduced in the gastric compartment of TIM-1 and samples were taken immediately after the pylorus. Moreover, for 6 h, every hour the ileal efflux was collected and a subsample was plated for viable counts (spores and germinated cells). The remainder of the sample was fed to TIM-2, and after 24 h another sample was taken and tested for viable counts. In addition, samples were taken from the dialysates of the model and analysed using LC-MS/MS to determine bacterial metabolites and digestion products. Survival after transit through the gastric compartment was high (97%) and most cells were still in the spore form (76%). Survival after transit through TIM-1 was on average 51%, meaning that on average half of the orally provided spores was found back as cfu on the agar plates. Of these on average 93% were germinated cells and only 7% were spores. 24 h after the start of the experiments germination had increased in TIM-2 to 97% vegetative cells, and only 3% spores. No further loss of viability was observed in TIM-2. In terms of metabolic activity, increased levels of amino acids, dipeptides and citric acid cycle metabolites were found compared to experiments in the absence of BC30. In conclusion, BC30 spores germinate to a large extent (>90%) in the presence of germination triggers in the small intestine in a model that closely mimics the physiological conditions of human adults. Of the oral dose, as much as half of the cells survived transit through the upper GI tract, and based on the metabolite profile, these cells were metabolically active. Either these cells or the enzymes released from the dead cells aided in digestion of the meal. These insights help explain some of the observations in previous experiments, and support the understanding of the mechanism of action of the probiotic BC30.